Effectiveness of Weekly Semaglutide (0.5 or 1 mg) in Chilean Adults with Type 2 Diabetes
Updated
Abstract
Semaglutide is approved in Chile for managing type 2 diabetes mellitus but is generally unavailable in the public health system.
- Local evidence on semaglutide's effectiveness may help integrate it into national guidelines.
- The current lack of availability contributes to a therapeutic gap compared to international standards.
- Incorporating local data could support better treatment options for patients with type 2 diabetes in Chile.
Simplified